Pharmaceutical companies face increasing pressure to demonstrate not only the efficacy of their treatments, but also the impact of these treatments on patients' lives.
In his recent speech on the need for NHS reform, the prime minister announced that support for preventative care in communities would be at the heart of the Government’s approach.
From consumer products to clinical trials, anything that is designed without input from its intended recipients will likely feel disconnected from their needs.
For over 30 years, the US has clung to an outdated and misguided war on testosterone, lumping it in with the anabolic steroids that come under the 1990 Anabolic Steroid Control Act.
Identifying the difference between customer and patient experiences in healthcare and why they shouldn’t be confused is integral to organisations delivering their services to people.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.